Cited by 832Genomics and Rare DiseasesClinical Laboratory Practices and Quality ControlPrenatal Screening and Diagnostics

ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007

Open access
Richards, C. Sue, Bale, Sherri, Bellissimo, Daniel B., Das, Soma, Grody, Wayne W., Hegde, Madhuri R., Lyon, Elaine, Ward, Brian E.·2008·Genetics in Medicine

Abstract

ACMG previously developed recommendations for standards for interpretation of sequence variations. We now present the updated revised recommendations. Here, we describe six interpretative categories of sequence variations: (1) sequence variation is previously reported and is a recognized cause of the disorder; (2) sequence variation is previously unreported and is of the type which is expected to cause the disorder; (3) sequence variation is previously unreported and is of the type which may or may not be causative of the disorder; (4) sequence variation is previously unreported and is probably not causative of disease; (5) sequence variation is previously reported and is a recognized neutral variant; and (6) sequence variation is previously not known or expected to be causative of disease, but is found to be associated with a clinical presentation. We emphasize the importance of appropriate reporting of sequence variations using standardized terminology and established databases, and of clearly reporting the limitations of sequence-based testing. We discuss follow-up studies that may be used to ascertain the clinical significance of sequence variations, including the use of additional tools (such as predictive software programs) that may be useful in variant classification. As more information becomes available allowing the interpretation of a new sequence variant, it is recommended that the laboratory amend previous reports and provide updated results to the physician. The ACMG strongly recommends that the clinical and technical validation of sequence variation detection be performed in a CLIA-approved laboratory and interpreted by a board-certified clinical molecular geneticist or equivalent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/gim.0b013e31816b5cae

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 11

  1. [1]1. Kazazian, H.H. ∙ Boehm, C.D. ∙ Seltzer, W.K. ACMG recommendation for standards for interpretation of sequence variations 10.1097/00125817-200009000-00009 Genet Med. 2000; 2:302-303 Google Scholar · DOI
  2. [3]3. db SNP at the National Center for Biotechnology Information in Bethesda, Maryland, 1988. Available at: www.ncbi.nlm.nih.gov/sites/entrez?db=snp Accessed November 26, 2007. Google Scholar
  3. [4]4. Fitze, G. ∙ Schreiber, M. ∙ Kuhlisch, E. ... Association of RET proto-oncogene codon 45 with Hirschsprung Disease 1:CAS:528:DyaK1MXns1Cksr8%3D 10.1086/302618 Am J Hum Genet. 1999; 65:1469-1473 Google Scholar · DOI
  4. [5]5. American College of Medical Genetics standards and guidelines for clinical genetics laboratories, 2007 edition. Available at: http://www.acmg.net/AM/Template.cfm?Section=Laboratory_Standards_and_Guidelines&Template=/CM/HTMLDisplay.cfm&ContentID=2009 Accessed November 26, 2007. Google Scholar
  5. [7]7. den Dunnen, J.T. ∙ Antonarakis, S.E. Nomenclature for the description of human sequence variations 1:CAS:528:DC%2BD3MXltlGqtLw%3D 10.1007/s004390100505 Hum Genet. 2001; 109:121-124 Google Scholar · DOI
  6. [8]8. den Dunnen, J.T. ∙ Antonarakis, S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion 1:CAS:528:DC%2BD3cXltV2htw%3D%3D 10.1002/(SICI)1098-1004(200001)15 Hum Mutat. 2000; 15:7-12 :1<7::AID-HUMU4>3.0.CO;2-N Google Scholar · DOI
  7. [10]10. NCBI refseq database at the National Center for Biotechnology Information in Bethesda, Maryland. Available at: http://www.ncbi.nlm.nih.gov/RefSeq/ Accessed November 28, 2007. Google Scholar
  8. [13]13. Grantham, R. Amino acid difference formula to help explain protein evolution 1:CAS:528:DyaE2cXlsVOiuro%3D 10.1126/science.185.4154.862 Science. 1974; 185:862-864 Google Scholar · DOI
  9. [14]14. Ng, P.C. ∙ Henikoff, S. SIFT: predicting amino acid changes that affect protein function 1:CAS:528:DC%2BD3sXltVWjs7s%3D 10.1093/nar/gkg509 Nucleic Acids Res. 2003; 31:3812-3814 Google Scholar · DOI
  10. [16]16. Berezin, C. ∙ Glaser, F. ∙ Rosenberg, Y. ... ConSeq: the identification of functionally and structurally important residues in protein sequences 1:CAS:528:DC%2BD2cXkt1Srtbw%3D 10.1093/bioinformatics/bth070 Bioinformatics. 2004; 20:1322-1324 Google Scholar · DOI
  11. [19]19. Social, Ethical and Legal Issues Committee ACMG policy statement: duty to recontact 10.1097/00125817-199905000-00010 Genet Med. 1999; 1:171-172 Google Scholar · DOI

Cited by

Sorted by citations

Authors
Richards, C. S., Bale, S., Bellissimo, D. B., Das, S., Grody, W. W., Hegde, M. R., Lyon, E., & Ward, B. E.
Affiliations
  • Oregon Health & Science University (US)
  • Versiti Blood Center of Wisconsin (US)
  • University of Chicago (US)
  • University of California, Los Angeles (US)
  • Emory University (US)
  • University of Utah (US)
  • Genomic Health (United States) (US)
Corresponding author
Richards, C. Sue
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2008-04
Volume
10
Issue
4
Pages
294-300
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2003873813
Cited by
832
References
0
Citations by year
2026: 14 · 2025: 28 · 2024: 34 · 2023: 35 · 2022: 51 · 2021: 56 · 2020: 45 · 2019: 44 · 2018: 55 · 2017: 58 · 2016: 76 · 2015: 97 · 2014: 84 · 2013: 55 · 2012: 36
FWCI
12.15
Type
journal article
Language
en
Open access
Locations
  • Genetics in Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
Keywords
ACMG guidelines, variant interpretation, variant reporting, clinical significance, genetic testing limitations, variant database, follow-up study
MeSH terms
Base Sequence, Genetics, Medical, Humans, Terminology as Topic, Research Design, Genetic Variation, Databases, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review